"The U.S. Food and Drug Administration today approved Zontivity (vorapaxar) tablets to reduce the risk of heart attack, stroke, cardiovascular death, and need for procedures to restore the blood flow to the heart in patients with a previous heart "...
Retavase Patient Information including If I Miss a Dose
In this Article
- What is retaplase (Retavase)?
- What are the possible side effects of retaplase (Retavase)?
- What is the most important information I should know about retaplase (Retavase)?
- What should I discuss with my health care provider before I receive retaplase (Retavase)?
- How is retaplase given (Retavase)?
- What happens if I miss a dose (Retavase)?
- What happens if I overdose (Retavase)?
- What should I avoid after receiving retaplase (Retavase)?
- What other drugs will affect retaplase (Retavase)?
- Where can I get more information?
What happens if I miss a dose (Retavase)?
Since retaplase is given only when needed by a healthcare professional, it is not likely that you will miss a dose.
What happens if I overdose (Retavase)?
An overdose of retaplase is not likely to occur.
What should I avoid after receiving retaplase (Retavase)?
Follow your doctor's instructions about any restrictions on food, beverages, or activity while you are using retaplase.
What other drugs will affect retaplase (Retavase)?
The following drugs can interact with retaplase. Tell your doctor if you are using any of these:
- a blood thinner such as warfarin (Coumadin);
- aspirin; or
- medication used to prevent blood clots, such as abciximab (ReoPro), dipyridamole (Persantine), and others.
This list is not complete and there may be other drugs that can interact with retaplase. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.
Where can I get more information?
Your doctor or pharmacist can provide more information about retaplase.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2012 Cerner Multum, Inc. Version: 1.03. Revision date: 12/15/2010.
Your use of the content provided in this service indicates that you have read,understood and agree to the End-User License Agreement,which can be accessed by clicking on this link.
Additional Retavase Information
Report Problems to the Food and Drug Administration
Get the latest treatment options.